BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025 04:00 ET | Source: BlackfinBio CHESHIRE, United Kingdom, April…
DOSIsoft PLANET Onco Dose receives CE MDR Mark and new FDA 510(k) clearance
PARIS, April 7, 2025 /PRNewswire/ -- DOSIsoft, leading provider of patient-specific imaging and…
Afcons Infrastructure – Raghavpur Multipurpose Project in Madhya Pradesh gets environmental clearance
MUMBAI, India, April 3, 2025 /PRNewswire/ -- The Madhya Pradesh State Environment Impact…
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and…
CORRECTION: RadNets DeepHealth Subsidiary Expands FDA Clearance for SmartMammo Solution
November 29, 2024 09:43 ET | Source: RadNet, Inc. SmartMammo™’s AI algorithm…
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology…
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology…
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology…
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) --…